Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)

This limited competition supports continuation of two national biospecimen banking resources that collect, process, store, and distribute clinically annotated human biospecimens from NCI-funded clinical trials. The NCTN Biobanks facilitate biomarker development and secondary studies, while the EET Biobank supports early-phase therapeutic trials, enabling translational research and novel cancer therapy development.

Eligibility is limited to institutions that currently operate an NCTN or EET Biobank funded under specific prior RFAs. Foreign organizations and foreign components of U.S. organizations are not eligible.